Bedier, Helbies, et al. “Long-Term Tolerance and Efficacy of Siltuximab (anti-IL-6) in a Young Adult With Idiopathic Multicentric Castleman Disease During COVID-19”. European Journal of Case Reports in Internal Medicine, vol. 10, no. 12, Nov. 2023, https://doi.org/10.12890/2023_004098.